BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31546933)

  • 21. DNA Methylation Analysis of the SHOX2 and RASSF1A Panel in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis.
    Zhang C; Yu W; Wang L; Zhao M; Guo Q; Lv S; Hu X; Lou J
    J Cancer; 2017; 8(17):3585-3591. PubMed ID: 29151944
    [No Abstract]   [Full Text] [Related]  

  • 22. Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA.
    Zhang YJ; Wu HC; Shen J; Ahsan H; Tsai WY; Yang HI; Wang LY; Chen SY; Chen CJ; Santella RM
    Clin Cancer Res; 2007 Apr; 13(8):2378-84. PubMed ID: 17438096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study.
    Cirincione R; Lintas C; Conte D; Mariani L; Roz L; Vignola AM; Pastorino U; Sozzi G
    Int J Cancer; 2006 Mar; 118(5):1248-53. PubMed ID: 16152615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylated APC and RASSF1A in multiple specimens contribute to the differential diagnosis of patients with undetermined solitary pulmonary nodules.
    Gao L; Xie E; Yu T; Chen D; Zhang L; Zhang B; Wang F; Xu J; Huang P; Liu X; Fang B; Pan S
    J Thorac Dis; 2015 Mar; 7(3):422-32. PubMed ID: 25922721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative DNA methylation analysis of selected genes in endometrial carcinogenesis.
    Chen YC; Tsao CM; Kuo CC; Yu MH; Lin YW; Yang CY; Li HJ; Yan MD; Wang TJ; Chou YC; Su HY
    Taiwan J Obstet Gynecol; 2015 Oct; 54(5):572-9. PubMed ID: 26522113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers.
    Panagopoulou M; Karaglani M; Balgkouranidou I; Biziota E; Koukaki T; Karamitrousis E; Nena E; Tsamardinos I; Kolios G; Lianidou E; Kakolyris S; Chatzaki E
    Oncogene; 2019 May; 38(18):3387-3401. PubMed ID: 30643192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients.
    Lissa D; Ishigame T; Noro R; Tucker MJ; Bliskovsky V; Shema S; Beck JA; Bowman ED; Harris CC; Robles AI
    Lung Cancer; 2018 Aug; 122():151-159. PubMed ID: 30032824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RASSF1A is not appropriate as an early detection marker or a prognostic marker for non-small cell lung cancer.
    Choi N; Son DS; Song I; Lee HS; Lim YS; Song MS; Lim DS; Lee J; Kim H; Kim J
    Int J Cancer; 2005 Jul; 115(4):575-81. PubMed ID: 15700308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Evaluation of the Factors Affecting Plasma Circulating Cell-Free DNA Levels and Their Application in Diagnosing Nonsmall Cell Lung Cancer.
    Chen Z; Zhang S; Li C; Xu C; Zhao J; Miao L
    Genet Test Mol Biomarkers; 2019 Apr; 23(4):270-276. PubMed ID: 30986099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients.
    Ponomaryova AA; Rykova EY; Cherdyntseva NV; Skvortsova TE; Dobrodeev AY; Zav'yalov AA; Bryzgalov LO; Tuzikov SA; Vlassov VV; Laktionov PP
    Lung Cancer; 2013 Sep; 81(3):397-403. PubMed ID: 23806794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer.
    Walter RFH; Rozynek P; Casjens S; Werner R; Mairinger FD; Speel EJM; Zur Hausen A; Meier S; Wohlschlaeger J; Theegarten D; Behrens T; Schmid KW; Brüning T; Johnen G
    PLoS One; 2018; 13(5):e0195716. PubMed ID: 29851970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter methylation of APC and RAR-β genes as prognostic markers in non-small cell lung cancer (NSCLC).
    Feng H; Zhang Z; Qing X; Wang X; Liang C; Liu D
    Exp Mol Pathol; 2016 Feb; 100(1):109-13. PubMed ID: 26681652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
    Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions.
    Jeronimo C; Monteiro P; Henrique R; Dinis-Ribeiro M; Costa I; Costa VL; Filipe L; Carvalho AL; Hoque MO; Pais I; Leal C; Teixeira MR; Sidransky D
    Breast Cancer Res Treat; 2008 May; 109(1):27-34. PubMed ID: 17549626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Value of the Methylation of Multiple Gene Promoters in Serum in Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Dong X; Hou Q; Chen Y; Wang X
    Dis Markers; 2017; 2017():2929381. PubMed ID: 28951629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of methylation status of locoregional lymph nodes in lung cancer using EBUS-NA.
    Millares L; Serra M; Andreo F; Sanz-Santos J; Montón C; Grimau C; Gallego M; Setó L; Combalia N; Llatjos M; Escoda R; Castellà E; Monsó E
    Clin Exp Metastasis; 2015 Oct; 32(7):637-46. PubMed ID: 26119430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
    Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.
    Yang X; Dai W; Kwong DL; Szeto CY; Wong EH; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lung ML
    Int J Cancer; 2015 Feb; 136(4):E127-35. PubMed ID: 25196065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
    Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
    Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RARβ2 gene methylation level in the circulating DNA from blood of patients with lung cancer.
    Ponomaryova AA; Rykova EY; Cherdyntseva NV; Skvortsova TE; Dobrodeev AY; Zav'yalov AA; Tuzikov SA; Vlassov VV; Laktionov PP
    Eur J Cancer Prev; 2011 Nov; 20(6):453-5. PubMed ID: 21795979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.